CorVel (NASDAQ:CRVL - Get Free Report) announced its quarterly earnings results on Tuesday. The business services provider reported $0.46 earnings per share for the quarter, Zacks reports. CorVel had a net margin of 9.64% and a return on equity of 31.73%.
CorVel Trading Down 5.6 %
CRVL traded down $6.83 during trading on Friday, reaching $115.94. The stock had a trading volume of 87,987 shares, compared to its average volume of 106,891. CorVel has a one year low of $76.20 and a one year high of $128.61. The company has a market capitalization of $5.91 billion, a price-to-earnings ratio of 73.84 and a beta of 1.16. The stock's 50 day moving average is $123.87 and its two-hundred day moving average is $112.35.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded CorVel from a "buy" rating to a "hold" rating in a report on Friday, January 3rd.
View Our Latest Research Report on CorVel
Insider Transactions at CorVel
In related news, EVP Mark E. Bertels sold 1,050 shares of the business's stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $119.12, for a total transaction of $125,072.50. Following the sale, the executive vice president now owns 2,580 shares of the company's stock, valued at $307,321. The trade was a 28.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 47.57% of the company's stock.
CorVel Company Profile
(
Get Free Report)
CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
See Also

Before you consider CorVel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.
While CorVel currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.